Theravance Biopharma Inc logo

TBPH

Theravance Biopharma Inc

$9.61

Earnings Summary

Revenue
$17.57Mn
Net Profits
$-8.51Mn
Net Profit Margins
-48.45%

Highlights

Revenue:

Theravance Biopharma Inc’s revenue jumped 19.91% since last year same period to $17.57Mn in the Q4 2023. On a quarterly growth basis, Theravance Biopharma Inc has generated 11.93% jump in its revenue since last 3-months.

Net Profits:

Theravance Biopharma Inc’s net profit jumped 40.31% since last year same period to $-8.51Mn in the Q4 2023. On a quarterly growth basis, Theravance Biopharma Inc has generated 4.91% jump in its net profits since last 3-months.

Net Profit Margins:

Theravance Biopharma Inc’s net profit margin jumped 50.22% since last year same period to -48.45% in the Q4 2023. On a quarterly growth basis, Theravance Biopharma Inc has generated 15.04% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Theravance Biopharma Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.25
EPS Estimate Current Year
-0.25

Highlights

EPS Estimate Current Quarter:

Theravance Biopharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.25 - a -66.67% fall from last quarter’s estimates.

EPS Estimate Current Year:

Theravance Biopharma Inc’s earning per share (EPS) estimates for the current year stand at -0.25.

Key Ratios

Key ratios of the Theravance Biopharma Inc post its Q4 2023 earnings

Earning Per Share (EPS)
-0.17

Highlights

Earning Per Share (EPS):

Theravance Biopharma Inc’s earning per share (EPS) fell -13.33% since last year same period to -0.17 in the Q4 2023. This indicates that the Theravance Biopharma Inc has generated -13.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-11-09
-0.21
-0.17
19.05%
2024-03-01
-0.15
-0.17
-13.33%
2023-08-09
-0.21
-0.28
-33.33%
2023-05-10
-0.26
-0.35
-34.62%